ATS 2020 Advance Program

There are more than 1.4 million oxygen users in the U.S and more worldwide. Reports reveal patients are not receiving manageable equipment, meets their portable oxygen needs, or adequate education and support from equipment providers. At the 2019 ATS Oxygen Symposium, the meeting room and overflow area exceeded attendee capacity highlighting clinician interest for additional guidance. Many care quality questions remain unanswered. Chairing: K.O. Lindell, PhD, RN, ATSF, Pittsburgh, PA S.S. Jacobs, RN, MS, Stanford, CA 9:15 Welcome K.O. Lindell, PhD, RN, ATSF, Pittsburgh, PA 9:20 Patient Education on Oxygen Equipment: Where We Are and What Do We Need as Patients B. Jackson, MS, Cincinnati, OH 9:40 Hospital to Home Oxygen Use in COPD Patients: Can We Decrease Mortality Risk? L.C. Feemster, MSc, MD, Seattle, WA 10:00 Standards of Care for Meeting the Oxygen Needs of ILD Patients During Rest, Exercise, and Sleep C.J. Ryerson, MD, Vancouver, Canada 10:20 The Finer Points of Portable Oxygen: Providing the Patient with the Most Appropriate Oxygen Delivery System(s) T.J. Kallstrom, MBA, RRT, Irving, TX 10:40 Advances in Oxygen Use in the Palliative and Hospice Care Settings A.M. Schneidman, MS, CNS, RN, ATSF, Phoenix, AZ 11:00 Panel Discussion with Q & A S.S. Jacobs, RN, MS, Stanford, CA BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM B7 LUNG CANCER SCREENING: SOMETHING OLD, SOMETHINGS NEW, SOMETHING BORROWED, SOMETHING BLUE Assemblies on Thoracic Oncology; Behavioral and Health Services Research; Clinical Problems; Nursing 9:15 a.m. - 11:15 a.m. Target Audience all physicians who care for patients with lung cancer; nurses and APPs who care for patients with lung cancer; health services researchers; translational scientists interested in how novel technologies/procedures can move into clinical practice Objectives At the conclusion of this session, the participant will be able to: • Learn new findings about landmark trials and influential guideline recommendations • Improve implementation of lung cancer screening using multidisciplinary care teams • Integrate new treatment options in discussing lung cancer screening with potentially eligible patients This symposium will briefly summarize the landmark lung cancer screening trial, the NLST and “lessons learned” on the 10 year anniversary of when the results were dropped. We will then dive deep into the current state of lung cancer screening along with new data and recommendations. We will include talks by representatives from NELSON, the USPSTF, and CMS to describe their data and recommendations. We will close with how new procedures/technologies may be used in the future and a panel discussion for how these new data and recommendations will affect future implementation efforts and outcomes. Chairing: C.G. Slatore, MD, Portland, OR R.S. Wiener, MD, MPH, Boston, MA N.T. Tanner, MD, MSCR, Charleston, SC 9:15 NLST: History and Lessons Learned C.D. Berg, MD, Bethesda, MD ATS 2020 • Philadelphia, PA 70 MONDAY • MAY 18